The genetics of thyroid associated ophthalmopathy

Thyroid

Volumn 8, Issue 5, 1998, Pages 407-409

  Farid, Nadir R ^a,b   Balazs, Csaba ^c  

^a Hemel Hempstead General Hospital   (United Kingdom)

^b Osancor Biotech Inc   (United Kingdom)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DISEASE ASSOCIATION; EXOPHTHALMOS; EYE DISEASE; GENE LOCUS; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; IMMUNOGENETICS; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; THYROID DISEASE;

EID: 0031746425     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1998.8.407     Document Type: Conference Paper

References (34)

1. Farid NR 1981 Graves' disease. In: Farid NR (ed) HLA in Endocrine and Metabolic Diseases. Academic Press, New York, 85-143.
2. Rundle FF, Wilson CW 1944 Development and course of exopthalmos and ophthalmoplegia in Graves' disease with special reference to the effect of thyroidectomy. Clin Sci 5:177-194.
3. Perros P, Crombie AL, Kendall-Taylor P 1995 Natural history of thyroid associated ophthalmopathy. Clin Endocrinol 42:45-50.
4. Osier W 1892 Principles and Practice of Medicine. D Appleton and Company, New York, pp 712-714.
5. Bahn RS, Heufelder AE 1993 Pathogenesis of Graves' ophthalmopathy. N Engl J Med 329:1468-1475.
6. Pappa A, Calder V, Ajjan R, Fells P, Ludgate M, Weetman AP, Lightman S 1997 Analysis of extraocular muscle-infiltrating T cells in thyroid-associated ophthalmopathy (TAO). Clin Exp Immunol 109:362-369.
7. Spitzweg C, Joba W, Hunt N, Heufelder AE 1997 Analysis of human thyrotropin receptor gene expression and immunoreactivity in human orbital tissue. Eur J Endocrinol 136:599-607.
8. Kiljanski J, Storarski C, Barsouk A, Nebes V, Wall JR 1996 Failure to demonstrate cell-mediated immunity to orbital tissue antigens and epitopic fragments of a 64 kDa protein in the majority of patients with thyroid associated ophthalmopathy. J Endocrinol Invest 19:284-292.
9. Zhang ZG, Wall JR, Bernard NF 1995 Identification of antigenic epitopes of ID antigen recognized by antibodies in the serum of patients with thyroid associated opthalmopathy. Clin Immunol Immunopathol 77:193-200.
10. Shine B, Fells P, Edwards OM, Weetman AP 1990 Association between Graves ophthalmopathy and smoking. Lancet 335:1261-1264.
11. Hofbauer LC, Muhlberg T, Konig A, Heufelder G, Schworm HD, Heufelder AE 1997 Soluble interleukin-1 receptor antagonist levels in smokers and nonsmokers with Graves' ophthalmopathy undergoing orbital radiotherapy. J Clin Endocrinol Metab 82:2244-2247.
12. Tellez M, Cooper J, Edmonds C 1992 Graves' ophthalmopathy in relation to cigarette smoking and ethnic origin. Clin Endocrinol 36:291-294.
13. Rundle FF, Pochin EE 1944 The orbital tissues in thyrotoxicosis: A quantitative analysis relating to exophthalmos. Clin Sci 5:51-74.
14. McGurk M, Whitehouse RW, Taylor PM, Swinson B 1992 Orbital volume measured by a low-dose CT scanning technique. Dentomaxillofac Radiol 21:70-72.
15. Brix TH, Christensen K, Holm NV, Harvald B 1997 Genetics versus environment in Graves' disease - A population based twin study. Program of the 70th Annual Meeting of the American Thyroid Association, Colorado Springs, Co, October 17-19, Abstract 9.
16. Stenszky V, Kozma L, Balazs C, Rochlitz S, Bear JC, Farid NR 1985 The genetics of Graves' disease: HLA and disease susceptibility. J Clin Endocrinol Metab 61:735-740.
17. Payami H, Joe S, Farid NR, Stenszky V, Chan SH, Yeo PP, Cheah JS, Thomson G 1989 Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves' disease. Am J Hum Genet 45:541-546.
18. Shields DC, Ratanachaiyavong S, McGregor Am, Collins A, Morton NE 1994 Combined segregation and linkage analysis of Graves' disease with a thyroid autoantibody diathesis. Am J Hum Genet 55:540-554.
19. Farid NR 1992 Understanding the genetics of autoimmune thyroid disease - Still an illusive goal! J Clin Endocrinol Metab 74:495A-495B.
20. Tomer Y, Barbesino G, Keddache M, Greenberg DA, Davies TF 1997 Mapping of a major susceptibility locus for Graves' disease (GD-1) to chromosome 14q31. J Clin Endocrinol Metab 82:1645-1648.
21. De Roux N, Shields DC, Mishari M, Ratanachaiyavong S, McGregor AM, Milgrom E 1996 Analysis of the thyrotropin receptor as a candidate gene in familial Graves' disease. J Clin Endocrinol Metab 81:3483-3486.
22. Kosta KD, Watson PF, Weetman AP 1997 No association between a thyrotropin receptor polymorphism and Graves' disease in the female population. Thyroid 7:31-33.
23. Barbesino G, Tomer Y, Concepcion ES, Keddache M, Greenberg DA, Davies TF 1997 Role of the estrogen receptor gene and the X chromosome in the genetic susceptibility to AITD. Program of the 70th Annual Meeting of the American Thyroid Association, Colorado Springs, Co, October 17-19, Abstract 204.
24. Ratanachaiyavong S, Demaine AG, Campell RD, McGregor AM 1991 Heat shock 70 (HSP70) and complement C4 genotypes inpatients with hyperthyroid Graves' disease. Clin Exp Immunol 84:48-52.
25. Rau H, Nicolay A, Usadel KH, Finke R, Donner H, Walfish PG, Badenhoop K 1997 Polymorphisms of TAP1 and TAP2 genes in Graves' disease. Tissue Antigens 49:16-22.
26. Cuddihy RM, Bahn RS 1996 Lack of an association between alleles of interleukin-1 and interleukin receptor -1 antagonist genes in Graves disease in a North American population. J Clin Endocrinol Metab 81:4476-4478.
27. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ 1995 CTLA-4 gene polymorphism is associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab 80:41-45.
28. Frecker M, Stenszky V, Balazs C, Kozma L, Kraszits E, Farid NR 1986 Genetic factors in Graves' ophthalmopathy. Clin Endocrinol 25:479-485.
29. Frecker M, Mercer G, Skanes VM, Farid NR 1988 Major histocompatibility complex (MHC) factors predisposing to and protecting against Graves' eye disease. Autoimmunity 1:307-315.
30. Inoue D, Sato K, Maeda M, Inoko H, Tsuji K, Mori T, Iura H 1991 Genetic differences shown by HLA typing among Japanese patients with euthyroid Graves' opthalmopathy, Graves' disease and Hashimoto's thyroiditis: Genetic characteristics of euthyroid Graves' ophthalmopathy. Clin Endocrinol 34:57-62.
31. Weetman AP, Zhang L, Webb S, Shine B 1990 Analysis of HLA-DQB and HLA-DPB alleles in Graves' disease by oligonucleotide probing of enzymatically amplified DNA. Clin Endocrinol 33:65-71.
32. Boehm BO, Kuhnl P, Manfras BJ, Chen M, Lee JC, Holzberger G, Seidl S, Schifferdecker E, Schumm-Draeger PM, Usadel KH 1992 HLA-DRB3 gene alleles in Caucasian patients with Graves' disease. Clin Invest 70:956-960.
33. Stenszky V, Balazs C, Kozma L, Rochlitz S, Bear JC, Farid NR 1983 Identification of subsets of patients with Graves' disease by cluster analysis. Clin Endocrinol 18:335-345.
34. Frecker MF, Preus M, Kozma L, Krasrits E, Stenszky V, Balazs C, Farid NR 1986 Heterogeneity by cluster analysis techniques of Graves' patients typed for HLA DR and IgG heavy chain markers. Mol Biol Med 3:63-71,